Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

NCT00003425 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Leukemia
Lymphoma
Neuroblastoma
Ovarian Cancer
Sarcoma
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: filgrastim
DRUG: amifostine trihydrate
DRUG: cyclophosphamide
DRUG: melphalan
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

University of Kentucky